IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Radiation Toxicity
Radiation Therapy Oncology Groupmonoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Radiation Toxicity cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM IRCCS San Raffaele | Phase 3 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Sun Yat-sen University | Phase 3 | BB |
ETOPOSIDE Sun Yat-sen University | Phase 3 | BB |
Amifostine Alliance for Clinical Trials in Oncology | Phase 3 | BB |
Carboplatin Sun Yat-sen University | Phase 3 | BB |
View all 37 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →